Free Trial

Venus Concept (VERO) Competitors

Venus Concept logo
$0.43
+0.02 (+4.88%)
(As of 11/1/2024 ET)

VERO vs. STRR, SSKN, ICU, PXDT, BTCY, GCTK, PAVM, PETV, NURO, and TTOO

Should you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Star Equity (STRR), STRATA Skin Sciences (SSKN), SeaStar Medical (ICU), Pixie Dust Technologies (PXDT), Biotricity (BTCY), GlucoTrack (GCTK), PAVmed (PAVM), PetVivo (PETV), NeuroMetrix (NURO), and T2 Biosystems (TTOO). These companies are all part of the "medical equipment" industry.

Venus Concept vs.

Venus Concept (NASDAQ:VERO) and Star Equity (NASDAQ:STRR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, community ranking, dividends, institutional ownership, analyst recommendations, earnings and valuation.

In the previous week, Star Equity had 1 more articles in the media than Venus Concept. MarketBeat recorded 1 mentions for Star Equity and 0 mentions for Venus Concept. Venus Concept's average media sentiment score of 0.00 equaled Star Equity'saverage media sentiment score.

Company Overall Sentiment
Venus Concept Neutral
Star Equity Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Venus Concept
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Star Equity
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Star Equity has lower revenue, but higher earnings than Venus Concept. Star Equity is trading at a lower price-to-earnings ratio than Venus Concept, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venus Concept$76.35M0.04-$37.25M-$8.38-0.05
Star Equity$45.78M0.25$25.13M-$2.79-1.29

Star Equity has a net margin of -14.65% compared to Venus Concept's net margin of -71.52%. Venus Concept's return on equity of 0.00% beat Star Equity's return on equity.

Company Net Margins Return on Equity Return on Assets
Venus Concept-71.52% N/A -43.68%
Star Equity -14.65%-5.74%-3.34%

Venus Concept has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500. Comparatively, Star Equity has a beta of 0.08, suggesting that its stock price is 92% less volatile than the S&P 500.

Venus Concept received 31 more outperform votes than Star Equity when rated by MarketBeat users. However, 100.00% of users gave Star Equity an outperform vote while only 65.38% of users gave Venus Concept an outperform vote.

CompanyUnderperformOutperform
Venus ConceptOutperform Votes
34
65.38%
Underperform Votes
18
34.62%
Star EquityOutperform Votes
3
100.00%
Underperform Votes
No Votes

87.4% of Venus Concept shares are owned by institutional investors. Comparatively, 3.8% of Star Equity shares are owned by institutional investors. 58.0% of Venus Concept shares are owned by company insiders. Comparatively, 33.5% of Star Equity shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Venus Concept and Star Equity tied by winning 7 of the 14 factors compared between the two stocks.

Get Venus Concept News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERO vs. The Competition

MetricVenus ConceptSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$3.12M$4.45B$5.40B$8.53B
Dividend YieldN/A42.37%5.15%4.14%
P/E Ratio-0.0537.84113.7615.14
Price / Sales0.0464.751,483.0493.53
Price / CashN/A49.2739.7134.04
Price / Book-0.184.214.665.01
Net Income-$37.25M$11.52M$119.06M$225.46M
7 Day Performance-6.11%1.05%0.79%0.37%
1 Month Performance-15.69%0.94%5.65%3.57%
1 Year Performance-77.60%39.40%36.80%29.42%

Venus Concept Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERO
Venus Concept
N/A$0.43
+4.9%
N/A-77.1%$3.12M$76.35M-0.05410Positive News
Gap Up
STRR
Star Equity
0.4129 of 5 stars
$3.79
+1.1%
N/A-20.2%$12.01M$47.15M-1.36171
SSKN
STRATA Skin Sciences
0.5364 of 5 stars
$3.18
+1.6%
N/A-39.4%$11.15M$32.73M-1.31120News Coverage
Gap Down
ICU
SeaStar Medical
0.2414 of 5 stars
$3.43
-3.7%
N/A-86.3%$11.05MN/A-0.172News Coverage
PXDT
Pixie Dust Technologies
1.6808 of 5 stars
$0.73
-9.4%
$5.21
+610.2%
-89.7%$10.91M$6.30M0.0078Gap Down
High Trading Volume
BTCY
Biotricity
N/A$0.47
+6.8%
N/A-59.0%$10.63M$12.06M-0.2740Gap Up
GCTK
GlucoTrack
0.8014 of 5 stars
$1.91
+10.3%
N/A+98.9%$10.49MN/A-0.795Short Interest ↓
Gap Up
PAVM
PAVmed
4.1617 of 5 stars
$1.09
-1.4%
$21.00
+1,818.2%
-73.0%$10.33M$3.83M-0.1390Positive News
PETV
PetVivo
N/A$0.50
-4.9%
N/A-61.3%$10.04M$1.05M-0.7820Gap Up
NURO
NeuroMetrix
0.5528 of 5 stars
$4.04
+0.7%
N/A+10.9%$8.20M$5.90M-0.7320
TTOO
T2 Biosystems
1.8145 of 5 stars
$0.92
-12.8%
$5.00
+446.4%
-85.7%$8.05M$7.16M0.00180Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:VERO) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners